Table 4.

Changes in continuous glucose monitoring data and dietary patterns in intervention group after controlling for patients’ baseline characteristics and missing data

	IP-weighted Coefficient	IP-weighted 95% Confidence Intervals
Mean glucose levels, mg/dl	−10.44	−21.83, 0.96
Glycemic variability measured through standard deviation	−3.94*	−7.59, − 0.29
Percentage of time in range (70–180 mg/dl)	7.25*	1.65, 12.85
Percentage of time above range (> 180 mg /dl)	− 6.10*	− 12.08, − 0.13
Percentage of time above range (> 250 mg /dl)	−3.05	− 8.03, 1.93
Percentage of time below range (< 70 mg/dl)	− 0.63	−1.39, 0.12
Percentage of time below range (< 54 mg/dl)	− 0.93	− 1.97, 0.09
Percentage of the area over the blood concentration-time curve	−8.01	− 17.5, 1.50
Percentage of the area under the blood concentration-time curve	− 0.15	− 0.32, 0.01
Dietary patterns
Daily caloric intake, Kcal/day
Total	− 197.66***	− 282.87, − 112.467
From carbohydrates	− 95.68***	−141.95, − 49.42
From proteins	−33.61***	−50.68, − 16.54
From fat	−62.75*	− 112.83, − 12.67

Each model was controlled for covariates (sex, age, educational level, nutritional status body mass index, time since diagnosis and type of pharmacological treatment) and the baseline treatment modification

*p < 0.05; **p < 0.01; ***p < 0.001